Literature Monitoring in Pharmacovigilance: Revolutionizing Drug Safety Management

In pharmacovigilance (PV), literature monitoring is pivotal in identifying, evaluating, and reporting adverse event (AE) information. Over time, PV processes have traditionally relied on manual efforts, with PV professionals meticulously sifting through vast amounts of data from various sources, including clinical trials, spontaneous reports, and medical literature. However, as the workload escalates while time remains fixed, the need for efficient literature monitoring in pharmacovigilance becomes increasingly evident. Organizations are turning to technology-enabled solutions to address these challenges to streamline the literature monitoring process, ultimately enhancing drug safety management.

The Growing Importance of Technology in Pharmacovigilance

Facing the mounting burden of AE reporting, PV organizations are exploring options to improve literature monitoring efficiency. Therefore, PV organizations have several options:

1. Increasing the workload on existing PV staff.
2. Enhancing resources for the PV department directly or through outsourcing.
3. Adopting technology-enabled strategies for more efficient operations.

However, options (i) and (ii) are not sustainable in the long term, leaving technology integration as the most viable solution. By leveraging technology-enabled processes, PV organizations can enhance AE identification and reporting accuracy and timeliness, ultimately improving drug safety outcomes.

Addressing Underreporting of Adverse Events

Literature monitoring in pharmacovigilance is conducive to technology integration due to various factors. Medical journals, where AE information is often reported, provide standardized medical language and are easily searchable in text format. Moreover, the rate of AEs discovered relative to the volume of articles reviewed is low, making it feasible for technology-enabled approaches to yield significant benefits in reviewing literature reports.

The Role of Technology in Literature Monitoring

Introducing DrugCards, a pioneering solution, is revolutionizing literature monitoring in pharmacovigilance across Europe and CIS countries. Committed to efficiency and precision, DrugCards offers an automated approach tailored to each client’s specific needs. Leveraging cutting-edge technology, DrugCards sifts through over 700 local medical journals, leaving no stone unturned in its quest to unearth critical safety information. Moreover, our DrugCard software scans medical journals with a remarkable 99% accuracy rate. With a seasoned team of experts and a comprehensive approach to literature monitoring, DrugCards ensures compliance and excellence in drug safety management.

Enhancing Pharmacovigilance Workflows

DrugCards’ flexible solutions adapt to clients’ evolving needs, automating the literature search process and preparing comprehensive safety analyses. Clients can trust that every decision is informed by the latest and most comprehensive data available, paving the way for safer and more effective medications.

Concluding Insights on DrugCards’ Literature Monitoring in Pharmacovigilance

In an era of rigorous regulations and the demand for cost-effective solutions, DrugCards shines as a leader in pharmacovigilance innovation. By leveraging cutting-edge technology and expertise, DrugCards empowers pharmaceutical manufacturers to maintain the highest drug safety standards. With DrugCards as your partner, you can trust that we meet and surpass your literature monitoring needs. This commitment ensures the ongoing safety and efficacy of pharmaceutical products while also minimizing your costs and resources.